Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-014603
Filing Date
2026-02-13
Accepted
2026-02-13 06:02:01
Documents
1
Period of Report
2025-08-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm266179-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm266179-1_4seq1.xml 4 11408
  Complete submission text file 0001104659-26-014603.txt   13020
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SILENCE THERAPEUTICS INC. 72 HAMMERSMITH ROAD LONDON United Kingdom W14 8TH
Business Address
Griffiths Richard Ian (Reporting) CIK: 0001846370 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 26628672